<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: The Real Problem With Those Vytorin Ads</title>
	<atom:link href="http://www.pharmalot.com/2008/04/the-real-problem-with-those-vytorin-ads/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/04/the-real-problem-with-those-vytorin-ads/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Sun, 21 Mar 2010 00:44:44 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: David</title>
		<link>http://www.pharmalot.com/2008/04/the-real-problem-with-those-vytorin-ads/#comment-290325</link>
		<dc:creator>David</dc:creator>
		<pubDate>Thu, 17 Apr 2008 15:54:41 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/04/the-real-problem-with-those-vytorin-ads/#comment-290325</guid>
		<description>Have any mainstream news reporters figured out that the most logical explanation for ENHANCE results is that the cardio-protective effects of statins are due to their anti-inflammatory effect that reduces the biomarker C-reactive protein (CRP), which was reduced more by Vytorin than by Zocor alone in the study that so many did not understand?

Are cardiologists more stupid than other medical specialists?  Stupidity and "group-think" herd mentality in support of the unsubstantiated "cholesterol is bad" theory is responsible for this tempest in a teapot, which MRK has not managed very well from a PR perspective, admittedly, likely because of the Vioxx aftermath.

Why don't cardiologists pay more attention to CRP than to the uncorrelated-with-outcomes cholesterol levels which they routinely focus on?

When i had a checku with a board certified internal medicine PCP, she wanted me on 80 mg of simvastatin based solely on my Total Cholesterol being slightly over 200.

She was clueless about CRP.</description>
		<content:encoded><![CDATA[<p>Have any mainstream news reporters figured out that the most logical explanation for ENHANCE results is that the cardio-protective effects of statins are due to their anti-inflammatory effect that reduces the biomarker C-reactive protein (CRP), which was reduced more by Vytorin than by Zocor alone in the study that so many did not understand?</p>
<p>Are cardiologists more stupid than other medical specialists?  Stupidity and &#8220;group-think&#8221; herd mentality in support of the unsubstantiated &#8220;cholesterol is bad&#8221; theory is responsible for this tempest in a teapot, which MRK has not managed very well from a PR perspective, admittedly, likely because of the Vioxx aftermath.</p>
<p>Why don&#8217;t cardiologists pay more attention to CRP than to the uncorrelated-with-outcomes cholesterol levels which they routinely focus on?</p>
<p>When i had a checku with a board certified internal medicine PCP, she wanted me on 80 mg of simvastatin based solely on my Total Cholesterol being slightly over 200.</p>
<p>She was clueless about CRP.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Dan</title>
		<link>http://www.pharmalot.com/2008/04/the-real-problem-with-those-vytorin-ads/#comment-282119</link>
		<dc:creator>Dan</dc:creator>
		<pubDate>Mon, 14 Apr 2008 13:45:42 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/04/the-real-problem-with-those-vytorin-ads/#comment-282119</guid>
		<description>While vaque, I mis-typed and missed the 90 day statement by DDMAC.  My apologies.</description>
		<content:encoded><![CDATA[<p>While vaque, I mis-typed and missed the 90 day statement by DDMAC.  My apologies.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Ed Silverman</title>
		<link>http://www.pharmalot.com/2008/04/the-real-problem-with-those-vytorin-ads/#comment-282069</link>
		<dc:creator>Ed Silverman</dc:creator>
		<pubDate>Mon, 14 Apr 2008 13:35:06 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/04/the-real-problem-with-those-vytorin-ads/#comment-282069</guid>
		<description>Hi Dan,

Please click on page three of the letter, which you can see by first clicking on 'read more.' You'll see that the FDA indicates the drugmakers had to reply by Feb. 6 and had 90 days to revise the ads. 

Cheers
ed</description>
		<content:encoded><![CDATA[<p>Hi Dan,</p>
<p>Please click on page three of the letter, which you can see by first clicking on &#8216;read more.&#8217; You&#8217;ll see that the FDA indicates the drugmakers had to reply by Feb. 6 and had 90 days to revise the ads. </p>
<p>Cheers<br />
ed</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Dan</title>
		<link>http://www.pharmalot.com/2008/04/the-real-problem-with-those-vytorin-ads/#comment-281758</link>
		<dc:creator>Dan</dc:creator>
		<pubDate>Mon, 14 Apr 2008 12:27:24 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/04/the-real-problem-with-those-vytorin-ads/#comment-281758</guid>
		<description>Equally interesting is that DDMAC is not requiring a response from the drugmakers, or a specific time for the drugmakers to respond.</description>
		<content:encoded><![CDATA[<p>Equally interesting is that DDMAC is not requiring a response from the drugmakers, or a specific time for the drugmakers to respond.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
